These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2483580

  • 1. Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
    Lepola U, Jolkkonen J, Rimón R, Riekkinen P.
    Neuropsychobiology; 1989; 21(4):182-6. PubMed ID: 2483580
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
    Eriksson E, Westberg P, Alling C, Thuresson K, Modigh K.
    Psychiatry Res; 1991 Mar; 36(3):243-51. PubMed ID: 1712114
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 6. The effect of chronic alprazolam on sleep and bioamine metabolites in depression.
    Zarcone VP, Benson KL, Greene KA, Csernansky JG, Faull KF.
    J Clin Psychopharmacol; 1994 Feb; 14(1):36-40. PubMed ID: 7512100
    [Abstract] [Full Text] [Related]

  • 7. Response of panic disorder to fixed doses of alprazolam or imipramine.
    Uhlenhuth EH, Matuzas W, Glass RM, Easton C.
    J Affect Disord; 1989 Feb; 17(3):261-70. PubMed ID: 2529295
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R, Kahn RJ, McNair DM, Frankenthaler LM.
    Psychopharmacol Bull; 1986 Feb; 22(1):167-72. PubMed ID: 2873609
    [No Abstract] [Full Text] [Related]

  • 10. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS, Woods SW.
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [Abstract] [Full Text] [Related]

  • 11. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 Nov; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 12. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 13. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
    Altemus M, Swedo SE, Leonard HL, Richter D, Rubinow DR, Potter WZ, Rapoport JL.
    Arch Gen Psychiatry; 1994 Oct; 51(10):794-803. PubMed ID: 7524463
    [Abstract] [Full Text] [Related]

  • 14. Lorazepam vs. alprazolam in the treatment of panic disorder.
    Schweizer E, Pohl R, Balon R, Fox I, Rickels K, Yeragani VK.
    Pharmacopsychiatry; 1990 Mar; 23(2):90-3. PubMed ID: 2187213
    [Abstract] [Full Text] [Related]

  • 15. Treatment of panic disorder with imipramine alone.
    Garakani H, Zitrin CM, Klein DF.
    Am J Psychiatry; 1984 Mar; 141(3):446-8. PubMed ID: 6367495
    [Abstract] [Full Text] [Related]

  • 16. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ, Bird ED, McEntee WJ.
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 20. The relationship of alprazolam dose to steady-state plasma concentrations.
    Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ.
    J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.